Solifenacin: study card

Solifenacin — Antimuscarinic (overactive bladder). Study the mechanism, listed uses and warnings from the US label on one sourced card.

Generic name: Solifenacin
Class: Antimuscarinic (overactive bladder)
Mechanism: Competitive muscarinic receptor antagonist; muscarinic receptors mediate cholinergic bladder smooth muscle contraction.
Used for: Overactive bladder with urgency, urinary frequency or urge urinary incontinence in adults
Common side effects: Dry mouth; Constipation; Urinary tract infection; Blurred vision
Warnings: Angioedema and anaphylaxis; Urinary retention (outlet obstruction); QT prolongation in high-risk patients
Interactions: Strong CYP3A4 inhibitors (e.g., ketoconazole)

Brand questions use only name pairings verified against the linked product source. Unverified pairings are withheld from these questions; the other study content remains available.

Drug class families: Antimuscarinic bladder medicines

Read the source label ↗

Label date: 20260706 · For learning, not clinical decisions. US label and brand information; always consult the current source.

Source snapshot checked: 2026-10-21. The source document and selected fields were compared. The complete card has not had an independent clinical review.

Practice

Pronunciation

Solifenacin: sol-i-FEN-a-sin

Pronunciation is shown for the US English generic name.

Other drugs in the same class

Antimuscarinic bladder medicines: Oxybutynin

Body system

Genitourinary · 11 Drug cards

Compare with related cards

Oxybutynin

Same class family: Antimuscarinic bladder medicines

Mechanism: Relaxes bladder smooth muscle by a direct antispasmodic effect and by inhibiting the muscarinic action of acetylcholine.

On both cards: Common side effects — Dry mouth; Constipation

Only on the Oxybutynin card: Used for — Overactive bladder with urge urinary incontinence, urgency and frequency; Symptoms of detrusor overactivity associated with a neurological condition in children aged 6 or older · Common side effects — Diarrhea; Headache; Somnolence · Warnings — Urinary retention, gastric retention or severe decreased gastrointestinal motility; uncontrolled narrow-angle glaucoma are contraindications; Angioedema; Anticholinergic CNS effects · Interactions — Other anticholinergic drugs; Prokinetic agents (metoclopramide)

Mirabegron

Same body system: Genitourinary

Mechanism: Activates beta-3 receptors, relaxing the detrusor during bladder filling and increasing bladder capacity.

On both cards: Common side effects — Urinary tract infection · Warnings — Urinary retention (outlet obstruction)

Only on the Mirabegron card: Used for — Overactive bladder in adults with urgency, urinary frequency or urge incontinence; Neurogenic detrusor overactivity in children aged 3 or older who weigh at least 35 kg, for the cited extended-release tablets · Common side effects — Hypertension; Nasopharyngitis; Headache · Warnings — Increased blood pressure; Angioedema · Interactions — Muscarinic antagonists for OAB

An item counts as shared only when both cards use the same wording. If a card does not list an item, that is not a statement that the effect never occurs.